The ongoing Iran-related conflict is creating significant challenges for India’s pharmaceutical exports to Africa, a region that depends heavily on Indian-made medicines. India supplies nearly one-fifth of Africa’s generic drugs and plays a vital role in supporting treatment programs for infectious and chronic diseases across the continent. Disruptions along major trade corridors, including routes connected to the Red Sea and Suez Canal, have forced shipping companies to adopt longer alternative paths, often around the Cape of Good Hope.
As a result, transit times have increased, freight rates have risen, and insurance costs have surged, placing additional pressure on exporters. Industry leaders warn that smaller pharmaceutical companies are particularly vulnerable to these rising logistics expenses. Prolonged disruptions could affect the timely delivery of essential medicines used in…
